DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Silperisone
Silperisone
WHO Drug Information Vol. 12, No. 3, 1998
Eperisone-Induced Anaphylaxis: Pharmacovigilance Data and Results of Allergy Testing
Ovid MEDLINE(R)
Sándor Farkas, MD
Tolperisone: a Typical Representative of a Class of Centrally Acting Muscle Relaxants with Less Sedative Side Effects
(12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
Fatal Tolperisone Poisoning: Autopsy and Toxicology findings in Three Suicide Cases
Florencio Zaragoza Dörwald Lead Optimization for Medicinal Chemists
Providing for Duty-Free Treatment for Specified Pharmaceutical Active
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
(12) United States Patent (10) Patent N0.: US 8,557,851 B2 Szelenyi Et A1
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Pharmaabkommen A1 E
Customs Tariff - Schedule Xxi - 1
Effects of Silperisone on the Excitation Process in Ranvier Nodes
Eperisone-Induced Anaphylaxis: Pharmacovigilance Data and Results of Allergy Testing
WO 2010/024870 Al
Top View
Sándor Farkas, MD
(12) Patent Application Publication (10) Pub. No.: US 2010/0226943 A1 Brennan Et Al
Immediate Allergic Reaction to Thiocolchicoside Confirmed by Skin Testing and Basophil Activation Test: a Case Report and Literature Review
Harmonized Tariff Schedule of the United States (2006) (Rev
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
Basic Aspects of the Pharmacodynamics of Tolperisone, a Widely Applicable Centrally Acting Muscle Relaxant
WO 2012/170676 Al 13 December 2012 (13.12.2012) P O P C T
PROCLAMATION 7207-^ULY 1, 1999 113 STAT. 2105 to Extend Nondiscriminatory Treatment
Schedule Clxxiii - European Union